Whit Mayo
Stock Analyst at Leerink Partners
(2.53)
# 2,333
Out of 4,960 analysts
150
Total ratings
51.52%
Success rate
10.41%
Average return
Main Sectors:
Stocks Rated by Whit Mayo
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ELV Elevance Health | Downgrades: Market Perform | $510 → $310 | $316.55 | -2.07% | 4 | Jul 18, 2025 | |
AIRS AirSculpt Technologies | Maintains: Market Perform | $6.5 → $2.5 | $6.50 | -61.54% | 5 | Mar 31, 2025 | |
AHCO AdaptHealth | Maintains: Buy | $12 → $11 | $9.61 | +14.46% | 11 | Feb 13, 2025 | |
EHAB Enhabit | Reiterates: Market Perform | $8.5 → $8 | $8.19 | -2.32% | 2 | Nov 19, 2024 | |
ARDT Ardent Health | Maintains: Outperform | $23 → $25 | $12.98 | +92.60% | 2 | Nov 12, 2024 | |
HUM Humana | Downgrades: Market Perform | $400 → $250 | $299.51 | -16.53% | 12 | Oct 2, 2024 | |
EHC Encompass Health | Initiates: Outperform | $100 | $122.83 | -18.59% | 1 | Jul 10, 2024 | |
BTSG BrightSpring Health Services | Initiates: Outperform | $15 | $24.87 | -39.69% | 1 | Feb 20, 2024 | |
UNH UnitedHealth Group | Maintains: Outperform | $625 → $560 | $307.42 | +82.16% | 11 | Jun 14, 2023 | |
UHS Universal Health Services | Upgrades: Outperform | n/a | $185.58 | - | 11 | May 26, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $98 → $97 | $115.48 | -16.00% | 1 | Apr 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $309 → $335 | $304.35 | +10.07% | 5 | Feb 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $238 → $286 | $404.97 | -29.38% | 17 | Dec 16, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $40 | $23.64 | +69.20% | 7 | Nov 22, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $39 | $21.97 | +77.51% | 7 | Nov 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $3 → $1.5 | $2.73 | -45.05% | 4 | Nov 8, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $30 | $1.33 | +2,155.64% | 5 | Nov 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $20 → $16 | $17.01 | -5.94% | 10 | Nov 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $89 → $55 | $179.50 | -69.36% | 14 | Oct 25, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $95 → $103 | $22.44 | +359.00% | 10 | Aug 26, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $235 → $175 | $92.05 | +90.11% | 1 | Apr 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $19 | $15.84 | +19.95% | 1 | Apr 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $4 | $2.76 | +44.93% | 6 | Jul 30, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $183 → $203 | $278.18 | -27.03% | 2 | May 1, 2018 |
Elevance Health
Jul 18, 2025
Downgrades: Market Perform
Price Target: $510 → $310
Current: $316.55
Upside: -2.07%
AirSculpt Technologies
Mar 31, 2025
Maintains: Market Perform
Price Target: $6.5 → $2.5
Current: $6.50
Upside: -61.54%
AdaptHealth
Feb 13, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $9.61
Upside: +14.46%
Enhabit
Nov 19, 2024
Reiterates: Market Perform
Price Target: $8.5 → $8
Current: $8.19
Upside: -2.32%
Ardent Health
Nov 12, 2024
Maintains: Outperform
Price Target: $23 → $25
Current: $12.98
Upside: +92.60%
Humana
Oct 2, 2024
Downgrades: Market Perform
Price Target: $400 → $250
Current: $299.51
Upside: -16.53%
Encompass Health
Jul 10, 2024
Initiates: Outperform
Price Target: $100
Current: $122.83
Upside: -18.59%
BrightSpring Health Services
Feb 20, 2024
Initiates: Outperform
Price Target: $15
Current: $24.87
Upside: -39.69%
UnitedHealth Group
Jun 14, 2023
Maintains: Outperform
Price Target: $625 → $560
Current: $307.42
Upside: +82.16%
Universal Health Services
May 26, 2023
Upgrades: Outperform
Price Target: n/a
Current: $185.58
Upside: -
Apr 3, 2023
Maintains: Overweight
Price Target: $98 → $97
Current: $115.48
Upside: -16.00%
Feb 8, 2023
Maintains: Market Perform
Price Target: $309 → $335
Current: $304.35
Upside: +10.07%
Dec 16, 2022
Maintains: Outperform
Price Target: $238 → $286
Current: $404.97
Upside: -29.38%
Nov 22, 2022
Maintains: Outperform
Price Target: $55 → $40
Current: $23.64
Upside: +69.20%
Nov 11, 2022
Maintains: Outperform
Price Target: $46 → $39
Current: $21.97
Upside: +77.51%
Nov 8, 2022
Maintains: Market Perform
Price Target: $3 → $1.5
Current: $2.73
Upside: -45.05%
Nov 4, 2022
Maintains: Outperform
Price Target: $33 → $30
Current: $1.33
Upside: +2,155.64%
Nov 4, 2022
Maintains: Market Perform
Price Target: $20 → $16
Current: $17.01
Upside: -5.94%
Oct 25, 2022
Maintains: Outperform
Price Target: $89 → $55
Current: $179.50
Upside: -69.36%
Aug 26, 2022
Maintains: Outperform
Price Target: $95 → $103
Current: $22.44
Upside: +359.00%
Apr 4, 2022
Maintains: Overweight
Price Target: $235 → $175
Current: $92.05
Upside: +90.11%
Apr 4, 2022
Initiates: Outperform
Price Target: $19
Current: $15.84
Upside: +19.95%
Jul 30, 2018
Maintains: Neutral
Price Target: $5 → $4
Current: $2.76
Upside: +44.93%
May 1, 2018
Assumes: Outperform
Price Target: $183 → $203
Current: $278.18
Upside: -27.03%